scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.74
3.04%
After-hours: Aug 15, 2025, 07:07 PM EDT

scPharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
16.04M 11.75M 12.15M 10.03M 8.05M 6.1M 6.1M 3.8M 1.64M 2.06M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
5.01M 3.47M 3.96M 3.31M 2.3M 1.84M 1.77M 1.08M 354K 605K 120K 118K 128K 102K 111K 112K 109K 106K
Gross Profit
11.03M 8.28M 8.19M 6.71M 5.75M 4.27M 4.32M 2.72M 1.28M 1.46M -120K -118K -128K -102K -111K -112K -109K -106K
Operating Income
-14.29M -17.76M -16.34M -18.15M -14.43M -15.86M -15.26M -14.84M -13.75M -11.55M -9.5M -9.99M -9.42M -7.24M -6.72M -5.91M -6.46M -6.74M
Interest Income
509K 716K 1M 903K 664K 877K 1.13M 1.3M 1.36M 1.31M 850K 232K 107K 13K 7K 10K 12K 20K
Pretax Income
-18.02M -19.74M -18.84M -35.1M -17.09M -14.11M -13.81M -15.63M -14.15M -11.21M -9.25M -10.16M -9.7M -7.73M -7.32M -6.55M -7.06M -7.1M
Net Income
-18.02M -19.74M -18.84M -35.1M -17.09M -14.11M -13.81M -15.63M -14.15M -12.83M -9.76M -10.33M -9.97M -8.22M -7.32M -6.55M -7.06M -7.1M
Selling & General & Admin
21.23M 21.41M 21.37M 21.32M 17.51M 17.4M 16.24M 14.13M 12.1M 10.9M 7.18M 6.28M 4.28M 2.89M 2.19M 2.21M 2.65M 2.73M
Research & Development
4.1M 4.63M 3.15M 3.54M 2.68M 2.73M 3.34M 3.42M 2.93M 2.12M 2.33M 3.72M 5.14M 4.35M 4.53M 3.69M 3.81M 4.01M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.36M -22K 64K 14K 17K 10K 33K 255K
Operating Expenses
25.32M 26.04M 24.53M 24.86M 20.18M 20.12M 19.58M 17.56M 15.03M 13.01M 9.5M 9.99M 9.42M 7.24M 6.72M 5.91M 6.46M 6.74M
Interest Expense
1.4M -1.39M 1.49M 1.85M 2.13M 2.1M 2.09M 2.06M 2.01M 1.96M 1.96M 377K 447K 518K 621K 667K 651K 636K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 16.32M -6.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
30.34M 29.51M 28.49M 28.17M 22.48M 21.96M 21.35M 18.64M 15.38M 13.62M 9.5M 9.99M 9.42M 7.24M 6.72M 5.91M 6.46M 6.74M
Income Tax Expense
n/a n/a -7.72K n/a n/a n/a n/a n/a n/a 1.62M 514K 167K 276K 491K n/a n/a n/a n/a
Shares Outstanding (Basic)
53.72M 53.68M 44.52M 46.56M 38.98M 38.95M 38.79M 38.76M 38.69M 37.8M 31.25M 27.4M 27.38M 27.37M 27.36M 27.3M 27.16M 27.34M
Shares Outstanding (Diluted)
53.72M 53.68M 44.52M 46.56M 38.98M 38.95M 38.79M 38.76M 38.69M 37.8M 31.25M 27.4M 27.38M 27.37M 27.36M 27.36M 27.36M 27.34M
EPS (Basic)
-0.34 -0.37 -0.42 -0.75 -0.44 -0.36 -0.36 -0.4 -0.37 -0.34 -0.31 -0.38 -0.36 -0.3 -0.27 -0.24 -0.26 -0.26
EPS (Diluted)
-0.34 -0.37 -0.42 -0.75 -0.44 -0.36 -0.36 -0.4 -0.37 -0.34 -0.31 -0.38 -0.36 -0.3 -0.27 -0.24 -0.26 -0.26
EBITDA
-14.29M -17.76M -17.3M -33.25M -14.9M -11.96M -11.58M -13.3M -12.04M -9.14M -7.17M -9.67M -9.12M -7.11M -6.59M -5.77M -6.3M -6.36M
EBIT
-16.62M -18.36M -17.36M -33.26M -14.96M -12.01M -11.72M -13.57M -12.14M -9.25M -7.29M -9.79M -9.25M -7.21M -6.7M -5.88M -6.41M -6.47M
Depreciation & Amortization
64K 63K -16K -87K 52K 51K 140K 272K 109K 105K 120K 118K 128K 102K 111K 112K 109K 106K